Welcome Address

Dear Friends and Colleagues,

Liquid biopsy is now revealing its tremendous potential to significantly change the therapeutic strategy and management of cancer patients.

It is a great pleasure to invite researchers from Academia and industry and clinicians from all over the world to the 6th Advances in Circulating Tumor Cells: “Liquid Biopsy and Precision Oncology: Where do we stand now??” meeting that will take place on Sep 20-23/2023 in the beautiful island of Skiathos, Greece.

The ACTC2023 meeting will focus on the latest advances and clinical applications of Liquid Biopsy in Precision oncology. Late breaking news on CTCs, ctDNA, circulating miRNAs and extracellular vesicles technologies and their clinical applications will be presented. The 6th ACTC meeting aims to bring together again researchers from academia, clinical oncologists and technology providers to present, discuss and share the latest information on liquid biopsy, and most importantly establish strong collaborations in a unique, relaxing and stimulating environment.  

I am really very glad that we will all have the chance to interact again two years after the ACTC2021 in-person meeting in Kalamata, during the difficult COVID-19 time! World recognized pioneer researchers and clinical oncologists that have major contributions in the field have already confirmed their participation to the ACTC2023 meeting.  State of the art research will be presented through selected oral presentations, and highly attended poster sessions. Latest findings on clinical trials based on liquid biopsy will be presented. Three travel grants and three poster awards will be granted to the best submitted abstracts.

I am looking forward to welcome you in Skiathos on September 20-23 2023!!  

Warm regards,


Evi S. Lianidou
University of Athens, Greece